Preeclampsia Therapeutic Market, Global Outlook and Forecast 2022-2028

August 2022 | 63 pages | ID: P397BB775037EN
Market Monitor Global

Abstracts

Medications to treat severe preeclampsia usually include: Antihypertensive drugs to lower blood pressure. Anticonvulsant medication, such as magnesium sulfate, to prevent seizures.

This report contains market size and forecasts of Preeclampsia Therapeutic in Global, including the following market information:

Global Preeclampsia Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Preeclampsia Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antihypertensive Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Preeclampsia Therapeutic include LFB S.A., A1M Pharma AB, AMAG Pharmaceuticals, VG Life Sciences,Inc., PerkinElmer Inc., Sera Prognostics,Inc., DRG INSTRUMENTS GMBH, F.Hoffmann-La Roche Ltd. and Pluristem Therapeutics Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preeclampsia Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Preeclampsia Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Preeclampsia Therapeutic Market Segment Percentages, by Type, 2021 (%)

• Antihypertensive Agents
• Anticonvulsants
• Antioxidants
• Others

Global Preeclampsia Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Preeclampsia Therapeutic Market Segment Percentages, by Application, 2021 (%)

• Mild Preeclampsia
• Severe Preeclampsia
• Others

Global Preeclampsia Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Preeclampsia Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Preeclampsia Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Preeclampsia Therapeutic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• LFB S.A.
• A1M Pharma AB
• AMAG Pharmaceuticals
• VG Life Sciences,Inc.
• PerkinElmer Inc.
• Sera Prognostics,Inc.
• DRG INSTRUMENTS GMBH
• F.Hoffmann-La Roche Ltd.
• Pluristem Therapeutics Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Preeclampsia Therapeutic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Preeclampsia Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PREECLAMPSIA THERAPEUTIC OVERALL MARKET SIZE

2.1 Global Preeclampsia Therapeutic Market Size: 2021 VS 2028
2.2 Global Preeclampsia Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Preeclampsia Therapeutic Players in Global Market
3.2 Top Global Preeclampsia Therapeutic Companies Ranked by Revenue
3.3 Global Preeclampsia Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Preeclampsia Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Preeclampsia Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Preeclampsia Therapeutic Players in Global Market
  3.6.1 List of Global Tier 1 Preeclampsia Therapeutic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Preeclampsia Therapeutic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Preeclampsia Therapeutic Market Size Markets, 2021 & 2028
  4.1.2 Antihypertensive Agents
  4.1.3 Anticonvulsants
  4.1.4 Antioxidants
  4.1.5 Others
4.2 By Type - Global Preeclampsia Therapeutic Revenue & Forecasts
  4.2.1 By Type - Global Preeclampsia Therapeutic Revenue, 2017-2022
  4.2.2 By Type - Global Preeclampsia Therapeutic Revenue, 2023-2028
  4.2.3 By Type - Global Preeclampsia Therapeutic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Preeclampsia Therapeutic Market Size, 2021 & 2028
  5.1.2 Mild Preeclampsia
  5.1.3 Severe Preeclampsia
  5.1.4 Others
5.2 By Application - Global Preeclampsia Therapeutic Revenue & Forecasts
  5.2.1 By Application - Global Preeclampsia Therapeutic Revenue, 2017-2022
  5.2.2 By Application - Global Preeclampsia Therapeutic Revenue, 2023-2028
  5.2.3 By Application - Global Preeclampsia Therapeutic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Preeclampsia Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Preeclampsia Therapeutic Revenue & Forecasts
  6.2.1 By Region - Global Preeclampsia Therapeutic Revenue, 2017-2022
  6.2.2 By Region - Global Preeclampsia Therapeutic Revenue, 2023-2028
  6.2.3 By Region - Global Preeclampsia Therapeutic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Preeclampsia Therapeutic Revenue, 2017-2028
  6.3.2 US Preeclampsia Therapeutic Market Size, 2017-2028
  6.3.3 Canada Preeclampsia Therapeutic Market Size, 2017-2028
  6.3.4 Mexico Preeclampsia Therapeutic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Preeclampsia Therapeutic Revenue, 2017-2028
  6.4.2 Germany Preeclampsia Therapeutic Market Size, 2017-2028
  6.4.3 France Preeclampsia Therapeutic Market Size, 2017-2028
  6.4.4 U.K. Preeclampsia Therapeutic Market Size, 2017-2028
  6.4.5 Italy Preeclampsia Therapeutic Market Size, 2017-2028
  6.4.6 Russia Preeclampsia Therapeutic Market Size, 2017-2028
  6.4.7 Nordic Countries Preeclampsia Therapeutic Market Size, 2017-2028
  6.4.8 Benelux Preeclampsia Therapeutic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Preeclampsia Therapeutic Revenue, 2017-2028
  6.5.2 China Preeclampsia Therapeutic Market Size, 2017-2028
  6.5.3 Japan Preeclampsia Therapeutic Market Size, 2017-2028
  6.5.4 South Korea Preeclampsia Therapeutic Market Size, 2017-2028
  6.5.5 Southeast Asia Preeclampsia Therapeutic Market Size, 2017-2028
  6.5.6 India Preeclampsia Therapeutic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Preeclampsia Therapeutic Revenue, 2017-2028
  6.6.2 Brazil Preeclampsia Therapeutic Market Size, 2017-2028
  6.6.3 Argentina Preeclampsia Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Preeclampsia Therapeutic Revenue, 2017-2028
  6.7.2 Turkey Preeclampsia Therapeutic Market Size, 2017-2028
  6.7.3 Israel Preeclampsia Therapeutic Market Size, 2017-2028
  6.7.4 Saudi Arabia Preeclampsia Therapeutic Market Size, 2017-2028
  6.7.5 UAE Preeclampsia Therapeutic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 LFB S.A.
  7.1.1 LFB S.A. Corporate Summary
  7.1.2 LFB S.A. Business Overview
  7.1.3 LFB S.A. Preeclampsia Therapeutic Major Product Offerings
  7.1.4 LFB S.A. Preeclampsia Therapeutic Revenue in Global Market (2017-2022)
  7.1.5 LFB S.A. Key News
7.2 A1M Pharma AB
  7.2.1 A1M Pharma AB Corporate Summary
  7.2.2 A1M Pharma AB Business Overview
  7.2.3 A1M Pharma AB Preeclampsia Therapeutic Major Product Offerings
  7.2.4 A1M Pharma AB Preeclampsia Therapeutic Revenue in Global Market (2017-2022)
  7.2.5 A1M Pharma AB Key News
7.3 AMAG Pharmaceuticals
  7.3.1 AMAG Pharmaceuticals Corporate Summary
  7.3.2 AMAG Pharmaceuticals Business Overview
  7.3.3 AMAG Pharmaceuticals Preeclampsia Therapeutic Major Product Offerings
  7.3.4 AMAG Pharmaceuticals Preeclampsia Therapeutic Revenue in Global Market (2017-2022)
  7.3.5 AMAG Pharmaceuticals Key News
7.4 VG Life Sciences,Inc.
  7.4.1 VG Life Sciences,Inc. Corporate Summary
  7.4.2 VG Life Sciences,Inc. Business Overview
  7.4.3 VG Life Sciences,Inc. Preeclampsia Therapeutic Major Product Offerings
  7.4.4 VG Life Sciences,Inc. Preeclampsia Therapeutic Revenue in Global Market (2017-2022)
  7.4.5 VG Life Sciences,Inc. Key News
7.5 PerkinElmer Inc.
  7.5.1 PerkinElmer Inc. Corporate Summary
  7.5.2 PerkinElmer Inc. Business Overview
  7.5.3 PerkinElmer Inc. Preeclampsia Therapeutic Major Product Offerings
  7.5.4 PerkinElmer Inc. Preeclampsia Therapeutic Revenue in Global Market (2017-2022)
  7.5.5 PerkinElmer Inc. Key News
7.6 Sera Prognostics,Inc.
  7.6.1 Sera Prognostics,Inc. Corporate Summary
  7.6.2 Sera Prognostics,Inc. Business Overview
  7.6.3 Sera Prognostics,Inc. Preeclampsia Therapeutic Major Product Offerings
  7.6.4 Sera Prognostics,Inc. Preeclampsia Therapeutic Revenue in Global Market (2017-2022)
  7.6.5 Sera Prognostics,Inc. Key News
7.7 DRG INSTRUMENTS GMBH
  7.7.1 DRG INSTRUMENTS GMBH Corporate Summary
  7.7.2 DRG INSTRUMENTS GMBH Business Overview
  7.7.3 DRG INSTRUMENTS GMBH Preeclampsia Therapeutic Major Product Offerings
  7.7.4 DRG INSTRUMENTS GMBH Preeclampsia Therapeutic Revenue in Global Market (2017-2022)
  7.7.5 DRG INSTRUMENTS GMBH Key News
7.8 F.Hoffmann-La Roche Ltd.
  7.8.1 F.Hoffmann-La Roche Ltd. Corporate Summary
  7.8.2 F.Hoffmann-La Roche Ltd. Business Overview
  7.8.3 F.Hoffmann-La Roche Ltd. Preeclampsia Therapeutic Major Product Offerings
  7.8.4 F.Hoffmann-La Roche Ltd. Preeclampsia Therapeutic Revenue in Global Market (2017-2022)
  7.8.5 F.Hoffmann-La Roche Ltd. Key News
7.9 Pluristem Therapeutics Inc.
  7.9.1 Pluristem Therapeutics Inc. Corporate Summary
  7.9.2 Pluristem Therapeutics Inc. Business Overview
  7.9.3 Pluristem Therapeutics Inc. Preeclampsia Therapeutic Major Product Offerings
  7.9.4 Pluristem Therapeutics Inc. Preeclampsia Therapeutic Revenue in Global Market (2017-2022)
  7.9.5 Pluristem Therapeutics Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Preeclampsia Therapeutic Market Opportunities & Trends in Global Market
Table 2. Preeclampsia Therapeutic Market Drivers in Global Market
Table 3. Preeclampsia Therapeutic Market Restraints in Global Market
Table 4. Key Players of Preeclampsia Therapeutic in Global Market
Table 5. Top Preeclampsia Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Preeclampsia Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Preeclampsia Therapeutic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Preeclampsia Therapeutic Product Type
Table 9. List of Global Tier 1 Preeclampsia Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Preeclampsia Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Preeclampsia Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Preeclampsia Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Preeclampsia Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Preeclampsia Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Preeclampsia Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Preeclampsia Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Preeclampsia Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Preeclampsia Therapeutic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Preeclampsia Therapeutic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Preeclampsia Therapeutic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Preeclampsia Therapeutic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Preeclampsia Therapeutic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Preeclampsia Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Preeclampsia Therapeutic Revenue, (US$, Mn), 2023-2028
Table 30. LFB S.A. Corporate Summary
Table 31. LFB S.A. Preeclampsia Therapeutic Product Offerings
Table 32. LFB S.A. Preeclampsia Therapeutic Revenue (US$, Mn), (2017-2022)
Table 33. A1M Pharma AB Corporate Summary
Table 34. A1M Pharma AB Preeclampsia Therapeutic Product Offerings
Table 35. A1M Pharma AB Preeclampsia Therapeutic Revenue (US$, Mn), (2017-2022)
Table 36. AMAG Pharmaceuticals Corporate Summary
Table 37. AMAG Pharmaceuticals Preeclampsia Therapeutic Product Offerings
Table 38. AMAG Pharmaceuticals Preeclampsia Therapeutic Revenue (US$, Mn), (2017-2022)
Table 39. VG Life Sciences,Inc. Corporate Summary
Table 40. VG Life Sciences,Inc. Preeclampsia Therapeutic Product Offerings
Table 41. VG Life Sciences,Inc. Preeclampsia Therapeutic Revenue (US$, Mn), (2017-2022)
Table 42. PerkinElmer Inc. Corporate Summary
Table 43. PerkinElmer Inc. Preeclampsia Therapeutic Product Offerings
Table 44. PerkinElmer Inc. Preeclampsia Therapeutic Revenue (US$, Mn), (2017-2022)
Table 45. Sera Prognostics,Inc. Corporate Summary
Table 46. Sera Prognostics,Inc. Preeclampsia Therapeutic Product Offerings
Table 47. Sera Prognostics,Inc. Preeclampsia Therapeutic Revenue (US$, Mn), (2017-2022)
Table 48. DRG INSTRUMENTS GMBH Corporate Summary
Table 49. DRG INSTRUMENTS GMBH Preeclampsia Therapeutic Product Offerings
Table 50. DRG INSTRUMENTS GMBH Preeclampsia Therapeutic Revenue (US$, Mn), (2017-2022)
Table 51. F.Hoffmann-La Roche Ltd. Corporate Summary
Table 52. F.Hoffmann-La Roche Ltd. Preeclampsia Therapeutic Product Offerings
Table 53. F.Hoffmann-La Roche Ltd. Preeclampsia Therapeutic Revenue (US$, Mn), (2017-2022)
Table 54. Pluristem Therapeutics Inc. Corporate Summary
Table 55. Pluristem Therapeutics Inc. Preeclampsia Therapeutic Product Offerings
Table 56. Pluristem Therapeutics Inc. Preeclampsia Therapeutic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Preeclampsia Therapeutic Segment by Type in 2021
Figure 2. Preeclampsia Therapeutic Segment by Application in 2021
Figure 3. Global Preeclampsia Therapeutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Preeclampsia Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Preeclampsia Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Preeclampsia Therapeutic Revenue in 2021
Figure 8. By Type - Global Preeclampsia Therapeutic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Preeclampsia Therapeutic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Preeclampsia Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Preeclampsia Therapeutic Revenue Market Share, 2017-2028
Figure 12. US Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Preeclampsia Therapeutic Revenue Market Share, 2017-2028
Figure 16. Germany Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 17. France Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Preeclampsia Therapeutic Revenue Market Share, 2017-2028
Figure 24. China Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. India Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Preeclampsia Therapeutic Revenue Market Share, 2017-2028
Figure 30. Brazil Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Preeclampsia Therapeutic Revenue Market Share, 2017-2028
Figure 33. Turkey Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Preeclampsia Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. LFB S.A. Preeclampsia Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. A1M Pharma AB Preeclampsia Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AMAG Pharmaceuticals Preeclampsia Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. VG Life Sciences,Inc. Preeclampsia Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PerkinElmer Inc. Preeclampsia Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sera Prognostics,Inc. Preeclampsia Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. DRG INSTRUMENTS GMBH Preeclampsia Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. F.Hoffmann-La Roche Ltd. Preeclampsia Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pluristem Therapeutics Inc. Preeclampsia Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)